We’re currently upgrading our membership platform to bring you an improved experience.
During this transition, access to member accounts is temporarily unavailable. We appreciate
your patience and can’t wait to share the new and improved system with you soon!
In our second introduction to plenary speakers at this year’s Annual Meeting…
Neuropsychiatric Symptoms in Women during Midlife and Breast Cancer Treatment: Emerging Trends and Therapeutic Strategies
Women are susceptible to both depression and sleep disorders during the menopause transition, driven by female-specific and menopause-related factors, as well as other risks such as stress exposures and their medical and psychiatric history.
These hormonal and menopause-related factors also contribute to mood and sleep disruption during the course of breast cancer treatment.
Hadine Joffe, MD, MSc
In her plenary presentation at this year’s Academy Annual Meeting, Neuropsychiatric Symptoms in Women during Midlife and Breast Cancer Treatment: Emerging Trends and Therapeutic Strategies, Hadine Joffe, MD, MSc, will discuss the clinical features, comorbid symptoms, risk factors, and treatment approaches for mood and sleep-related symptoms.
The presentation will cover the best treatment strategies, including hormone therapy, serotonergic agents, other psychotropics, as well as behavioral interventions.
Learning objectives are to:
Understand the course of depressive and sleep disorders in women over the lifespan.
Characterize hormonal, stress, and other female-specific contributors to sleep and depression risk.
Identify clinical strategies for treatment approaches for depressive and sleep disorders across menopause, and in the context of breast cancer anti-estrogen therapies.
Dr. Joffe is Paula A. Johnson professor of Psychiatry in the field of women’s health at Harvard Medical School (HMS) and executive director of the Connors Center for Women’s Health Research at Brigham and Women’s Hospital, where she directs the Women’s Hormones and Aging Research Program. She is also affiliated with the HMS Division of Sleep Medicine and the Dana Farber Cancer Institute’s Department of Supportive Oncology and Breast Cancer Program.
Dr. Joffe obtained her undergraduate degree from Harvard University, medical degree from Cornell University Medical College, master’s degree in epidemiology from Harvard School of Public Health, Psychiatry residency training at McLean Hospital, and Reproductive Psychiatry fellowship at Massachusetts General Hospital.
She is an experienced academic leader, clinician, and clinical reproductive neuroscientist whose research focuses on brain health across menopause and in breast cancer survivors. Her research examines the mechanisms (neural, hormonal, stress, autonomic), course, downstream consequences (body fat gain, anti-estrogen adherence), and treatment of neurocognitive symptoms (depression, insomnia, thermoregulatory disturbance, cognition, fatigue).
Dr. Joffe’s contributions have been recognized through the HMS William Silen Lifetime Achievement in Mentoring Award, HMS Department of Psychiatry Stuart T. Hauser MD PhD Mentorship Award, Brigham and Women’s Hospital Distinguished Clinician Award, and national awards (Executive Leadership in Academic Medicine Fellowship, Vivian Pinn Award for Outstanding Research in Women’s Health, Thomas Clarkson Outstanding Clinical & Basic Science Research Award).
Registration for this year’s ACLP Annual Meeting is open. Register here. The Annual Meeting—Innovation in C-L Psychiatry: Exploring the Promise and Pitfalls of New Approaches,in San Antonio, Texas, November 19-22—includes plenary presentations aboutoptogenetics,the potential clinical applications of artificial intelligence and large language models, as well as advances in women’s mental health.
Hotel reservationsare also open. ACLP has secured a discounted rate of $235 per night (plus taxes and fees) exclusively for meeting attendees at the meeting venue, the JW Marriott San Antonio Hill Country Resort & Spa. Rooms are limited and tend to fill quickly. We encourage you to reserve early to ensure you’re at the center of the meeting experience.
The Academy of Consultation-Liaison Psychiatry is a professional organization of physicians who provide psychiatric care to people with coexisting psychiatric and medical illnesses, both in hospitals and in primary care. Our specialty is called consultation-liaison psychiatry because we consult with patients and liaise with their other clinicians about their care.
With nearly 2,000 members, the Academy is the voice of consultation-liaison psychiatry in the US with international reach.
Please browse our website, read our journal, Psychosomatics, and come to our annual meeting which is in November each year. In 2020 it will be a virtual event – see www.CLP2020.org for more details.
If you are a C-L Psychiatrist and not yet a member please join our great organization and welcoming, inclusive community. Please visit this page for details on joining.
